| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/20/2008 | US20080070861 Therapy for infections such as hepatitis virus using a (2'R)-2'-deoxy-2'-fluoro-2'-C-methyl nucleosides; rhinovirus; Dengue virus (DENV) or West Nile virus |
| 03/20/2008 | US20080070860 Purine nucleoside analogs that are selective ligands of the purine salvage pathway enzyme adenosine phosphorylase (AP) found in bacteria and protozoa; 2-chloro-5'-deoxyadenosine; 2-chloro-6-methylpurine-5'-deoxyriboside |
| 03/20/2008 | US20080070859 Treats neoplastic disorders, infections from fungal or fungal-like organisms and other parasites |
| 03/20/2008 | US20080070858 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 03/20/2008 | US20080070857 Comprises a substance that inhibits expression of macrophage migration inhibitory factor (MIF) such as siRNA of MIF; adenocarcinoma or colon cancer |
| 03/20/2008 | US20080070856 Medicament to treat a fibrotic disease |
| 03/20/2008 | US20080070855 Preventing post-operative neovascularization in ophthalmic tissue; administering bevacizumab |
| 03/20/2008 | US20080070854 Conserved Hbv and Hcv Sequences Useful for Gene Silencing |
| 03/20/2008 | US20080070852 Immunomodulators; therapy and prophylaxis of infections caused by adenovirus, cytomegalovirus, hepatitis A virus (HAV), hepatitis B virus (HBV), flaviviruses including Yellow Fever virus, herpes virus; 5-Amino-3-(5'-O-L-valinyl- beta -D-ribofuranosyl)thiazolo[4,5-d]pyrimidine-2,7-dione Dihydrochloride |
| 03/20/2008 | US20080070851 Method for the extraction of pharmaceutically active products from spermatophyte plants, products thus obtained and their use in the medical field, in particular as substances with immunomodulating activity |
| 03/20/2008 | US20080070850 Have a linker molecule that misaligns the carbohydrate cores; structurally simpler, easier to synthesize, and more potent; low toxicity; anticancer; 1,1'-O-2,2',3,3',4,4',6,6'-tetrakis(3,4,5-trihydroxybenzoyl)- beta , beta '-D,D'-glucopyranosylterephthalate |
| 03/20/2008 | US20080070849 Synergistic combinations of the compound 5,6-dimethylxanthenone-4-acetic acid (DMXAA) and a compound selected from carboplatin, gemcitabine, cisplatin, 5-fluorouracil, cyclophosphamide, etoposide, vincristine, doxorubicin and irinotecan |
| 03/20/2008 | US20080070848 Anti-cancer combinations |
| 03/20/2008 | US20080070847 Administering 5,6-dimethylxanthenone-4-acetic acid and and administering a compound selected from platinum compounds, vinca alkaloids, alkylating agents, anthracyclines, topoisomerase I inhibitors, antimetabolites and topoisomerase II inhibitors for therapy of cancer |
| 03/20/2008 | US20080070846 Treating acute exacerbations of asthma using a ketolide |
| 03/20/2008 | US20080070845 Blocks the absorption of ingested fats from the small intestines; osteoporosis; Fat soluble vitamin deficiencies |
| 03/20/2008 | US20080070844 Method for treating wounds to promote healing |
| 03/20/2008 | US20080070839 Composition and method for treating cancer |
| 03/20/2008 | US20080070836 Zinc transporter LIV1 can be used as an epithelial-mesenchymal transition (EMT) regulatory agent; further, because EMT is involved in cancer progression, LIV1 antisense nucleotides and the like may be used as pharmaceuticals for treating cancer |
| 03/20/2008 | US20080070831 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 03/20/2008 | US20080070830 Homing of cells to myocardium |
| 03/20/2008 | US20080070826 Cholesterol-reducing diet |
| 03/20/2008 | US20080070789 Process for making amlodipine, derivatives thereof, and precursors therefor |
| 03/20/2008 | US20080070305 Inhibition of expression of a target gene |
| 03/20/2008 | US20080070267 changing the pattern of Ca2+ spike activity of the neuron; treating psychological disorder using electrical or chemical stimulants, or antagonist; altering neurotransmitter expression; autism, anxiety disorder, post-traumatic stress disorder, depression, bipolar disorder and schizophrenia |
| 03/20/2008 | US20080070239 Using concentration of calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase activating peptide (PACAP) as diagnostic indicators for bladder, bowel and/or reproductive tissue/organ disorders |
| 03/20/2008 | US20080069932 cooking oil contains high diacylglycerol content, a plant sterol and a plant sterol fatty acid ester; darkening discoloration inhibition, photostability |
| 03/20/2008 | US20080069913 Anti-Snoring Composition |
| 03/20/2008 | US20080069910 Preventive, Relieving or Therapeutic Composition for Diabetes Mellitus and/or Diabetic Nephropathy |
| 03/20/2008 | US20080069909 Using plant extracts; side effect reduction |
| 03/20/2008 | US20080069904 Inhibition of angiogenesis through nitric oxide tachyphylaxis |
| 03/20/2008 | US20080069902 For example, glycerol initiated multiarm polyethylene glycol modified with a polypeptide and then conjugated to a drug such as 5-fluorouracil; high drug-carrying capability; useful for hydrophilic and charge-bearing drugs as well |
| 03/20/2008 | US20080069900 Combination chemotherapy compositions and methods |
| 03/20/2008 | US20080069899 In mixture with drug that prevents Dna reproduction |
| 03/20/2008 | US20080069889 Mixture of polysaccharide and binder; reverse agglomeration |
| 03/20/2008 | US20080069888 Modified release formulations of at least one form of tramadol |
| 03/20/2008 | US20080069886 Spironolactone nanoparticles, compositions and methods related thereto |
| 03/20/2008 | US20080069885 Sustained release microparticle; a biodegradable and biocompatible polymer; active agent risperidone, 9-hydroxy-risperidone; pharmaceutically acceptable acid addition salts; inhibiting serotonergic or dopaminergic overstimulation |
| 03/20/2008 | US20080069884 Administered intraarticular into synovial fluid; water soluble |
| 03/20/2008 | US20080069883 Applying to body tissue; adjust circulation; mixture containing penetration intensifiers, polymeric thickener, lipophic compound , water and buffer |
| 03/20/2008 | US20080069882 Mixture of active material in matrix of fatty alcohol or acid and solid hydrocarbon; microsphere |
| 03/20/2008 | US20080069881 Abuse-resistant controlled-release opioid dosage form |
| 03/20/2008 | US20080069879 Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof |
| 03/20/2008 | US20080069878 Mixture of drug with mixture of water insoluble polymer and enteric polymer coating |
| 03/20/2008 | US20080069877 Chewable, Suckable and Swallowable Tablet Containing a Calcium-Containing Compound as an Active Substance |
| 03/20/2008 | US20080069872 Maintenance of therapeutic concentration in blood; core with protective coating |
| 03/20/2008 | US20080069870 Pulsed release; oral administering |
| 03/20/2008 | US20080069868 Irinotecan Preparation |
| 03/20/2008 | US20080069866 Immunotherapeutic methods and compositions |
| 03/20/2008 | US20080069865 Congestive heart failure; antiischemic agents; administering calcitonin gene related peptide in thermoplastic biocompatible polymer; controlled release or maintenance therapy |
| 03/20/2008 | US20080069862 Mixture of collagen, chondroitin sulfate, glucosamine sulfate with metal compounds and herbs |
| 03/20/2008 | US20080069860 Administering a rare earth compound with calcium and aluminum salt or hydrophilic exchange resin in foods |
| 03/20/2008 | US20080069859 Method for treating neovascularization and intravitreal implants |
| 03/20/2008 | US20080069857 Aqueous solution containing polysaccharides; insertion into body cavity; crosslinking |
| 03/20/2008 | US20080069855 Method of inhibiting the formation of adhesions and scar tissue and reducing blood loss |
| 03/20/2008 | US20080069851 Substituted n-aminomethylene sulfonamides, production and use thereof as medicaments |
| 03/20/2008 | US20080069850 Drug delivery; releasing drug from substrate loaded with active materials; contraceptive, bactericides, fungicides, viricides; sustained release |
| 03/20/2008 | US20080069840 Immunotherapy ; antigen codes Dna vaccine; antitumor agents |
| 03/20/2008 | US20080069837 Composition and method for treating cancer using herpes virus |
| 03/20/2008 | US20080069834 Moderation of gene expression; administering antioxidant to mammals; reduce oxidation stresses |
| 03/20/2008 | US20080069831 Vaccines; fusion protein; induce immunology response |
| 03/20/2008 | US20080069830 Isolation Dna; nucleotide sequences; genetic engineering |
| 03/20/2008 | US20080069827 miRNA of HSV-LAT and uses thereof |
| 03/20/2008 | US20080069825 Multiple CpG oligodeoxynucleotides and their use to induce an immune response |
| 03/20/2008 | US20080069819 Method and composition for detecting cancer by means of detection of epstein-barr virus nuclear antigen 2 coactivator p100 |
| 03/20/2008 | US20080069818 Method of Increasing Efficacy of Tumor Cell Killing Using Combinations of Anti-Neoplastic Agents |
| 03/20/2008 | US20080069817 Heteroaryl-fused pyrimidinyl compounds as anticancer agents |
| 03/20/2008 | US20080069814 High dosage administered without inducing severe symptomatic hypercalcemia |
| 03/20/2008 | US20080069811 Follicle stimulating hormone (Fsh); bioavailability; drug screening |
| 03/20/2008 | US20080069808 Ec Sod and Cell Transducing Ec Sod and Use Thereof |
| 03/20/2008 | US20080069801 Methods and apparatus for using polymer-based beads and hydrogels for cardiac applications |
| 03/20/2008 | US20080069797 Rapamycin and il-10 for the treatment of immune diseases |
| 03/20/2008 | US20080069795 Depleting T cells in the patient prior to a administration of a platinum-containing compound |
| 03/20/2008 | US20080069794 Inducing vasodilation; chewign gum, confectionary and pet foods with enhanced levels of cocoa polyphenol |
| 03/20/2008 | US20080069793 Surfactant-free cosmetic, dermatological and pharmaceutical agents |
| 03/20/2008 | US20080069792 Polyamino acid derivatives and use thereof in compositions for treating keratin fibers |
| 03/20/2008 | US20080069789 N-(2-Thiophen-2-ylethyl)benzene-1,4-diamine; hair dye; very strong and sparingly selective coloration of keratin fibers, light fast, avoiding the degradation of the fibers |
| 03/20/2008 | US20080069775 Administering anti-idiotype antibody or antibody fragment comprising heavy chain variable region sequences and light chain variable region sequences conjugated to a soluble immunogenic carrier protein |
| 03/20/2008 | US20080069774 Targeting ligand specifically binding to an extracellular component of a cellular system, masking the extracellular component from interacting with a component of the cellular system; thrombotic occlusion and loss of vessel patency at the site of the vascular intervention |
| 03/20/2008 | US20080069772 Treatment of transformed or infected biological cells |
| 03/20/2008 | US20080069770 Monoclonal antibodies; used to modulate the immune system; no modulation of the totality of the T-cell population but only of the sub-assembly of T-cells expressing the beta sub-family specific to the T-cell receptors; used for organ transplant rejection |
| 03/20/2008 | US20080066744 Process for producing metered dose inhaler formulations |
| 03/20/2008 | DE69717831C5 Substituierte 2-(2,6-dioxopiperidin-3-yl)-phthalimide und -1-oxoisoindoline und verfahren zur reduzierung des tnf-alpha-spiegels Substituted 2- (2,6-dioxopiperidin-3-yl) -1-oxoisoindoline and -phthalimides and method for reducing the TNF-alpha levels |
| 03/20/2008 | DE202005021414U1 Festes und kristallines Ibandronat-Natrium Solid and crystalline ibandronate sodium |
| 03/20/2008 | DE102007037830A1 Indolinsulfonamidverbindungen Indolinsulfonamidverbindungen |
| 03/20/2008 | DE102006041382A1 Carbamoyl-Sulfoximide als Proteinkinaseinhibitoren Carbamoyl-sulphoximides as protein kinase inhibitors |
| 03/20/2008 | DE102006040915A1 New oxindole derivatives useful for treating vasopressin- or oxytocin-dependent diseases |
| 03/20/2008 | DE102006039912A1 Substituierte Spirotetronsäuren und ihre Verwendung Substituted Spirotetronsäuren and their use |
| 03/20/2008 | DE102006037786A1 Nukleoside, diese enthaltendes Arzneimittel und deren Verwendung Nucleosides containing these drugs and their use |
| 03/20/2008 | DE102006030479A1 Indazolderivate Indazole derivatives |
| 03/20/2008 | DE10080167B4 Medikament zur Hemmung der Expression eines vorgegebenen Gens Medicament for inhibiting the expression of a given gene |
| 03/20/2008 | CA2664315A1 Dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances |
| 03/20/2008 | CA2664251A1 Isovaline for treatment of pain |
| 03/20/2008 | CA2664009A1 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | CA2663947A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | CA2663577A1 Kinase inhibitors useful for the treatment of proliferative diseases |
| 03/20/2008 | CA2663544A1 Isoserine derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2663543A1 Tartrate derivatives for use as coagulation factor ixa inhibitors |
| 03/20/2008 | CA2663504A1 Azetidine and azetidone derivatives useful in treating pain and disorders of lipid metabolism |
| 03/20/2008 | CA2663503A1 Azetidinone derivatives and methods of use thereof |